 |
|
Modified Goeckerman Therapy for PsoriasisA Two-Year Follow-up of a Combined Hospital-Ambulatory Care Program
Robert B. Armstrong, MD;
Eileen E. Leach, RN;
Joseph L. Fleiss, PhD;
Leonard C. Harber, MD
Arch Dermatol. 1984;120(3):313-318.
Abstract
• Two groups totaling 162 patients hospitalized for modified Goeckerman treatment of severe psoriasis were matched for sex, age, and season of admission and followed up for two years after discharge. One group remained hospitalized throughout their average 20.8-day course; the other half was hospitalized 14 days, then transferred to an ambulatory center for the remainder of a course averaging 20.8 days. No difference was detected between the groups in the duration that improvement equaled or exceeded progress achieved at discharge. The percentage of patients remaining continuously improved after discharge was 80% at one month, 55% at six months, 40% at 12 months, and 20% at 24 months. Rates of relapse requiring readmission or alternate therapy were also similar: 75% had not relapsed by 12 months and 60% had not relapsed by 24 months.
(Arch Dermatol 1984;120:313-318)
Author Affiliations
From the Department of Dermatology, Columbia University, College of Physicians and Surgeons (Drs Armstrong and Harber, and Ms Leach), the Dermatology Service of Presbyterian Hospital (Drs Armstrong and Harber) and the Division of Biostatistics, Columbia University, School of Public Health (Dr Fleiss), New York.
Footnotes
Accepted for publication Sept 16, 1983.
Reprint requests to Department of Dermatology, Columbia University, 630 W 168th St, New York, NY 10032 (Dr Armstrong).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cost-effectiveness and Cost-Benefit Analysis of Using Methotrexate vs Goeckerman Therapy for Psoriasis: A Pilot Study
Chen et al.
Arch Dermatol 1998;134:1602-1608.
ABSTRACT
| FULL TEXT
UV-B: Unanswered Questions
Stern
Arch Dermatol 1984;120:1437-1439.
ABSTRACT
|
